openPR Logo
Press release

Tuberculosis (TB) Therapeutics Market Size & Growth Analysis Report, 2019-2025

01-29-2021 09:56 AM CET | Health & Medicine

Press release from: Orion Market Research

Tuberculosis (TB) Therapeutics Market Size & Growth Analysis

Global tuberculosis (TB) therapeutics market is anticipated to grow at a significant CAGR of over 4% during the forecast period. Government initiatives for promoting education about tuberculosis diagnosis and treatment among the population will drive the market growth. Multiple partnerships with government and non-government organizations have been the major key strategy adopted by market players globally. These collaborations have been aiming for eliminating tuberculosis from society by supplying an adequate number of drugs to several countries as well as government organizations.

Moreover, increasing spending on R&D for the development of new drugs tend to drive the growth of global tuberculosis (TB) therapeutics market during the forecast period. Funding for research and development in the field of tuberculosis treatment will offer a huge opportunity for the global tuberculosis therapeutics industry across the globe. Funding for R&D has been increasing significantly over past levels, and other institutional barriers to research and development have been resolved.

Request a Free Sample of our Tuberculosis (TB) Therapeutics Market: https://www.omrglobal.com/request-sample/tuberculosis-tb-therapeutics-market

In 2017, Funding for TB care and prevention reached $6.9 billion in 118 low and middle-income countries. Funding on research and developments in 2016 was $6.3 billion and it was more than double the funding in 2006 which was approximately $3.3 billion. Such an increase in funding on tuberculosis tends to provide ample opportunity for the growth of global tuberculosis (TB) therapeutics market in the near future.

Johnson and Johnson Services Inc., Lupin Ltd., Otsuka Pharmaceutical Co. Ltd., Macleods Pharmaceuticals Ltd., Merck & Co. Inc., Novartis International AG, and Pfizer Inc are some of the key players operating in global tuberculosis (TB) therapeutics industry. The players are collaborating with non-profit organizations to meet the needs of the people. For instance, in 2019., Macleods Pharmaceuticals Ltd. collaborated with TB Alliance for a new therapy for highly drug-resistant TB. Macleods Pharmaceuticals was granted a non-exclusive license by TB Alliance to manufacture the anti-TB drug pretomanid as part of the three-drug “BPaL” regimen. Such collaborations tend to expand global tuberculosis (TB) therapeutics market size in the near future.

A full Report of Tuberculosis (TB) Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/tuberculosis-tb-therapeutics-market

Global Tuberculosis (TB) Therapeutics Market Segmentation

By Disease Type

• Active TB
• Latent TB
By Therapy

• First-Line Therapy
• Second-Line Therapy

Global Tuberculosis (TB) Therapeutics Market – Segmentation by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World

Company Profiles

• Akorn Inc.
• AstraZeneca Plc
• Biochemical and Synthetic Products Pvt Ltd.
• Eli Lilly & Co.
• GlaxoSmithKline Plc
• Johnson and Johnson Services Inc.
• LabatecPharma SA
• Lupin Ltd.
• Macleods Pharmaceuticals Ltd.
• Merck& Co. Inc.
• Mylan N.V.
• Novartis International AG
• Otsuka Pharmaceutical Co. Ltd.
• Pfizer Inc.
• Sanofi SA

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/tuberculosis-tb-therapeutics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tuberculosis (TB) Therapeutics Market Size & Growth Analysis Report, 2019-2025 here

News-ID: 2232987 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for Tuberculosis

Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032. Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does. March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region. Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model. Ocular tuberculosis is a type